A phase I trial of nab-paclitaxel/bevacizumab (AB160) nano-immunoconjugate therapy for metastatic gynecological malignancies: MC1371 (NCT02020707). This is an ASCO ...
Journal of the Royal Statistical Society. Series C (Applied Statistics), Vol. 30, No. 3 (1981), pp. 349-352 (4 pages) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback